Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2008;67:1650-1651; doi:10.1136/ard.2007.085951
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism.

Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis

A Spadaro, F Ceccarelli, R Scrivo, G Valesini

Dipartimento di Clinica e Terapia Medica, Rheumatology Unit, Università di Roma, Rome, Italy

Correspondence to:
Professor Antonio Spadaro, Dipartimento di Clinica e Terapia Medica, Rheumatology Unit, Sapienza, Università di Roma, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161 Rome, Italy; a.spadaro.reuma@virgilio.it

Accepted 7 February 2008

The first 150 words of the full text of this article appear below.

The recent analysis of data included in the Stockholm TNF{alpha} Follow- Up (STURE) registry showed that the concomitant use of methotrexate (MTX) with etanercept (ETN), adalimumab or infliximab was associated with long-term drug survival of anti-tumour necrosis factor (TNF) agents in patients with psoriatic arthritis (PsA).1 The positive effect of MTX was primarily linked to fewer drop-outs due to adverse events.1 This analysis did not consider each anti-TNF drug subgroup. For this reason we determined the cumulative probability of taking ETN with or without MTX in a large cohort of patients.

We prospectively studied 82 patients, admitted to our rheumatological unit since 2001, affected by PsA, classified according to Moll and Wright criteria, modified by Helliwell et al,2 treated with ETN alone or in combination with MTX. The main clinical demographic features of each patient were recorded, including the pattern of articular involvement. Clinical assessment was performed according to . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • SPADARO, A., SCRIVO, R., SPINELLI, F. R., VALESINI, G. (2009). Monitoring Biological Therapies in Psoriatic Arthritis. The Journal of Rheumatology Supplement 83: 69-70 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs